Patient-perceived symptomatic benefits of olanzapine treatment for nausea and vomiting in patients with advanced cancer who received palliative care through consultation teams: a multicenter prospective observational study

被引:0
作者
Isseki Maeda
Eriko Satomi
Daisuke Kiuchi
Kaoru Nishijima
Yoshinobu Matsuda
Akihiro Tokoro
Keita Tagami
Yoshihisa Matsumoto
Akemi Naito
Tatsuya Morita
Satoru Iwase
Hiroyuki Otani
Takuya Odagiri
Hiroaki Watanabe
Masanori Mori
Yosuke Matsuda
Hiroka Nagaoka
Meiko Mayuzumi
Yoshiaki Kanai
Nobuhiro Sakamoto
Keisuke Ariyoshi
机构
[1] Senri-Chuo Hospital,Department of Palliative Care
[2] National Cancer Center Hospital,Department of Palliative Medicine
[3] Kobe University Graduate School of Medicine,Department of Palliative Medicine
[4] National Hospital Organization Kinki-Chuo Chest Medical Center,Department of Psychosomatic Internal Medicine
[5] Tohoku University Graduate School of Medicine,Department of Palliative Medicine
[6] National Cancer Center Hospital East,Department of Palliative Medicine
[7] Miyazaki Medical Association Hospital,Department of Palliative Care
[8] Seirei Mikatahara General Hospital,Palliative and Supportive Care Division
[9] Saitama Medical University,Department of Palliative Medicine
来源
Supportive Care in Cancer | 2021年 / 29卷
关键词
Cancer; Palliative care; Olanzapine, Japan; Nausea; Vomiting;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:5831 / 5838
页数:7
相关论文
共 175 条
[1]  
Walsh D(2017)2016 Updated MASCC/ESMO consensus recommendations: management of nausea and vomiting in advanced cancer Support Care Cancer 25 333-340
[2]  
Davis M(2006)An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer Support Care Cancer 14 348-353
[3]  
Ripamonti C(2019)The nature of nausea: prevalence, etiology, and treatment in patients with advanced cancer not receiving antineoplastic treatment Support Care Cancer 27 3071-3080
[4]  
Bruera E(2013)Olanzapine: palliative medicine update Am J Hosp Palliat Care 30 75-82
[5]  
Davies A(1996)Radioreceptor binding profile of the atypical antipsychotic olanzapine Neuropsychopharmacology 14 87-96
[6]  
Molassiotis A(2020)Antiemetics: ASCO Guideline Update J Clin Oncol 38 2782-2797
[7]  
Stephenson J(2015)A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients Crit Rev Oncol Hematol 95 214-221
[8]  
Davies A(2020)The use of olanzapine as an antiemetic in palliative medicine: a systematic review of the literature BMC Palliat Care 19 56-532
[9]  
Harder S(2002)A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain J Pain Symptom Manag 23 526-255
[10]  
Herrstedt J(2003)Olanzapine for intractable nausea in palliative care patients J Palliat Med 6 251-582